Bencycloquidium bromide nasal spray is effective and safe for persistent allergic rhinitis: a phase III, multicenter, randomized, double-blinded, placebo-controlled clinical trial
Conclusion90 μg BCQB per nostril four times daily is effective and safe in the treatment of rhinorrhea as well as sneezing, nasal congestion and itching for patients with PAR.Retrospectively registeredChiCTR2000030924, 2020/3/17.
Source: European Archives of Oto-Rhino-Laryngology - Category: ENT & OMF Source Type: research
More News: Allergy & Immunology | China Health | Clinical Trials | ENT & OMF | Hay Fever | Rhinoscopy